The landscape of dementia diagnosis has evolved dramatically with the arrival of sophisticated biomarkers, which include amyloid PET scans, tau imaging, and blood-based assessments that can detect Alzheimer's pathology a long time right before signs arise. While these technological improvements characterize outstanding progress in being familiar wi